Other
Nuevolution
develops small molecule drug therapeutics for the treatment of cancer and chronic inflammatory diseases... Read moreNuevolution
develops small molecule drug therapeutics for the treatment of cancer and chronic inflammatory diseases... Read moreNews
Jul 27, 2019
CentralCharts
Press Release: Nuevolution : Amgen Controls 98% Of The Shares In Nuevolution After The End Of The Extended Acceptance Period
Jul 12, 2019
FinanzNachrichten
Nuevolution: Nasdaq Stockholm AB: Correction of exchange notice (124/19). Delisting from Nasdaq Stockholm of Nuevolution AB (publ) (125/19)
May 27, 2019
BioPortfolio
Nuevolution: Amgen acquires Nuevolution after 'highspeed' development progress
May 22, 2019
Pharmaceutical Manufacturing
Nuevolution: Amgen scoops up biopharma company Nuevolution
May 22, 2019
Cision
Nuevolution: Nuevolution expands its patent portfolio
May 22, 2019
BioSpace
Nuevolution: Nuevolution AB (publ) Announces its Results for the First Quarter of 2019
May 22, 2019
Reuters
Nuevolution: Amgen offers to buy Copenhagen-based Nuevolution for $167 mln
May 15, 2019
Cision
Nuevolution: Nuevolution AB (publ) announces timing for the release and webcast of the first quarter 2019 interim results
May 09, 2019
Cision
Nuevolution: Nuevolution's BET-BD1 selective inhibitor and candidate compound, NUE20798, shows positive effect on disease scoring and biomarker levels in an atopic dermatitis (eczema) mouse model
Apr 17, 2019
4-traders
Nuevolution: Nuevolution publ : AGM Proxy form UK
Nuevolution Competitors
1
2
3
4
5
6
7
8
9
10